Lex Smiles Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 27 Muzzey St, Lexington, MA 02421 Phone: 781-698-7136 Fax: 781-860-9841 |
Avetis Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 62 Massachusetts Ave, Lexington, MA 02420 Phone: 781-863-9826 |
Rose L Wang, Dmd Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 394 Lowell St, Suite 2, Lexington, MA 02420 Phone: 781-862-3333 |
Lexington Family Dental Care Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 62 Massachusetts Ave, Lexington, MA 02420 Phone: 781-863-9826 Fax: 781-863-9829 |
Sam W. Levine, D.d.s., M.s., P.c. Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 18 Muzzey St, Lexington, MA 02421 Phone: 781-860-9473 |
Lexington Dental Group Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 35 Bedford St Ste 16, Lexington, MA 02420 Phone: 781-863-0096 |
News Archive
A two-day conference examining the effectiveness of a pilot program aimed at improving the coherence and effectiveness of U.N. assistance is taking place this week in Ha Noi, Vietnam, South Asian News Agency reports.
The World Health Organization (WHO) declared the Zika virus infection a global threat during the peak of its outbreak in 2016. Since then, scientists and health experts raced to understand the virus better to develop novel and effective vaccines and treatments for the disease. Now, a team of researchers in China revealed how a protein in the virus reshapes its host to boost viral replication.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today an exclusive partnership agreement with Therabel Group for the European commercialization rights of Loramyc® and Setofilm® including France and the associated French commercial structure to a newly established entity, Therabel Hôpital Pharma.
Early detection is key to more effective treatment for Alzheimer's disease and other forms of cognitive impairment, and new research shows that a test developed at the University of Tennessee is more than 95 percent effective in detecting cognitive abnormalities associated with these diseases.
› Verified 1 days ago